HKB's Mouse Passive Heymann Nephritis Models provide pharmaceutical researchers with robust platforms for investigating membranous nephropathy, a leading cause of nephrotic syndrome in adults. Our validated rodent models utilize anti-Fx1A antibody injection to replicate key features of membranous nephropathy including subepithelial immune complex deposition, podocyte damage, and proteinuria.